NafoA.18681.a
prolyl-trna synthetase
CENTER ID:
NafoA.18681.a
ORGANISM:
Naegleria fowleri ATCC 30863
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
IIB
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
NafoA.18681.a.B2.GE40322
ordered domain
info
31
535
NafoA.18681.a.B2.GE40322
NafoA.18681.a.B3.GE42995
rescue 2
info
28
477
NafoA.18681.a.B3.GE42995
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
NafoA.18681.a.B2.PW38555
ordered domain
info
31
535
PW38555
NafoA.18681.a.B2.PW38711
ordered domain
info
31
535
PW38711
Structures
6NAB
DEPOSITED: 12/5/2018
DETERMINATION: XRay
CLONE: NafoA.18681.a.B2.GE40322
PROTEIN: NafoA.18681.a.B2.PW37988
6UYH
DEPOSITED: 11/13/2019
DETERMINATION: XRay
CLONE: NafoA.18681.a.B2.GE40322
PROTEIN: NafoA.18681.a.B2.PW37988
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MSDQPASSNN NKEKKSKPAK QQQQGSSSGL KQNEGIDVKK QENFSEWYSQ VITKSEFLDY YDVSGCYIFR PNCWFVWESV QKFFDAEIKK LGVQNVMFPL FVTKRALETE KDHVEGFSPE VAWVTKSGNS DLQEPIALRP TSETIMYPSY AKWIQSHRDL PLKLNQWTNV VRWEFKHAVP FIRSREFYWQ EGHSAFKSKE EADEEVFTIL ELYKRVYEEL LAVPVIKGTK TENEKFAGAD YTTTVETFIA TNGRAVQGGT SHHLGQNFSK MFKIQFEAEN KETQFAYQNS WGLSTRTLGV MIMVHGDDKG MVLPPRVAFC QVVVIPLIFK DKDNATLVEK TKEIYNELEK AGIRVKLDDR LERTPGWKYN YWELRGVPLR IEVGPKDLEK QQIMLCRRDT GEKWTMPLSE FSGDSIKAVL DKIHDSMLNK ARKEMNERIV VTRTWPEFIK ALNSGNMCLI PWHESKAAEE YIKEKSKLES VQSQSDANTG LTGAAKSLCV PLDQSSFPSL EGLENFYPEE AHKKPNCWAL FGRSY
NT Sequence
ATGTCCGATC AACCAGCATC ATCCAACAAT AACAAGGAGA AGAAATCCAA ACCAGCAAAG CAACAACAAC AAGGTTCTTC TTCTGGTCTC AAACAAAACG AAGGTATTGA TGTCAAGAAG CAAGAAAACT TTAGCGAATG GTACAGCCAA GTCATCACCA AGAGTGAATT CTTGGATTAC TATGATGTGA GTGGATGTTA TATTTTCAGA CCAAATTGTT GGTTTGTTTG GGAGTCTGTT CAAAAGTTCT TTGATGCAGA AATTAAAAAG TTGGGTGTTC AAAATGTCAT GTTTCCATTG TTTGTTACCA AGAGAGCTTT GGAAACTGAG AAGGACCACG TTGAAGGCTT CTCTCCAGAA GTTGCTTGGG TCACCAAGTC CGGTAATTCG GATCTTCAAG AACCAATTGC TTTGAGACCA ACAAGTGAAA CCATCATGTA TCCATCGTAT GCCAAGTGGA TTCAATCTCA CAGAGATTTG CCATTAAAAT TGAACCAATG GACAAACGTT GTTAGATGGG AATTTAAACA TGCTGTTCCT TTCATTAGAT CCAGAGAATT CTACTGGCAA GAAGGTCACA GTGCTTTCAA ATCAAAGGAA GAAGCTGATG AAGAAGTTTT TACTATTTTG GAGTTATATA AAAGAGTTTA CGAAGAATTG TTGGCTGTTC CAGTCATCAA GGGTACCAAG ACTGAAAATG AAAAGTTTGC TGGAGCCGAC TACACAACTA CTGTGGAAAC TTTCATTGCT ACAAACGGAA GAGCAGTACA AGGAGGTACA AGCCATCACT TGGGACAAAA TTTCTCAAAG ATGTTCAAGA TTCAATTCGA AGCTGAAAAC AAGGAGACAC AATTTGCTTA CCAAAATTCA TGGGGCTTGT CAACTCGTAC TCTCGGTGTC ATGATTATGG TTCACGGAGA TGACAAGGGT ATGGTTTTAC CACCAAGAGT TGCTTTCTGC CAAGTTGTCG TTATTCCACT CATCTTCAAG GACAAGGATA ACGCCACTTT GGTAGAAAAG ACCAAGGAAA TTTATAATGA GCTTGAAAAG GCTGGAATTC GTGTCAAGTT GGATGATCGT TTGGAGAGAA CTCCAGGTTG GAAATACAAT TATTGGGAAC TCCGTGGTGT TCCATTGCGT ATTGAAGTTG GACCAAAGGA TTTGGAAAAG CAACAAATTA TGCTCTGTAG AAGAGACACA GGAGAAAAGT GGACCATGCC ACTCAGTGAA TTTTCTGGTG ATTCCATTAA GGCCGTTCTT GATAAAATTC ATGACTCCAT GTTGAACAAG GCCAGAAAGG AAATGAATGA AAGAATTGTA GTGACAAGAA CATGGCCAGA GTTCATCAAG GCACTCAACT CTGGAAATAT GTGTCTTATT CCTTGGCATG AAAGCAAGGC AGCAGAGGAA TATATTAAGG AAAAGTCAAA GTTGGAAAGT GTCCAAAGTC AATCTGATGC CAACACAGGT TTAACAGGAG CTGCCAAATC ATTGTGTGTC CCTCTCGACC AATCTTCCTT CCCATCATTG GAAGGTCTTG AGAACTTTTA TCCTGAAGAA GCTCACAAGA AGCCAAATTG TTGGGCTTTG TTCGGTAGAA GTTAT
Details for NafoA.18681.a.B2.GE40322
HARVESTED ON:
6/13/2016
SEQUENCED ON:
6/16/2016
EXPECTED MW:
59kDa
OBSERVED MW:
60kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
data unavailable
SEQUENCING RESULT:
PERCENT IDENTITY:
97
PERCENT COVERAGE:
50
Details for NafoA.18681.a.B3.GE42995
HARVESTED ON:
3/4/2019
SEQUENCED ON:
3/12/2019
EXPECTED MW:
53kDa
OBSERVED MW:
53kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Insoluble
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for NafoA.18681.a.B2.PW38555
PURIFICATION DATe:
10/29/2018
CONCENTRATION:
16.56mg/ml
OBSERVED MW:
55kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7, 500 mM NaCl, 5% Glycerol , 2 mM DTT, 0.025% Azide, 1 mM ATP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
7
VIAL VOLUME:
200µl
PERCENT IDENTITY:
97
PERCENT COVERAGE:
50
Details for NafoA.18681.a.B2.PW38711
PURIFICATION DATe:
9/30/2019
CONCENTRATION:
87.9mg/ml
OBSERVED MW:
60kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide, 1 mM ATP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
15
VIAL VOLUME:
110µl
PERCENT IDENTITY:
97
PERCENT COVERAGE:
50